SecFilingDex

Eledon Pharmaceuticals, Inc.

40 SEC EDGAR filings indexed (CIK 0001404281) across 13 form types.

Filing profile

Eledon Pharmaceuticals, Inc. (ELDN) has 40 SEC filings indexed on SecFilingDex, across 13 form types filed over roughly 2 years, from October 31, 2024 to August 13, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 28 of these filings were disclosed in the twelve months to August 13, 2026. 6 of the 40 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 88-KMaterial event · event-driven
  • 8Form 4Insider transaction · within 2 business days of transaction
  • 610-QQuarterly report · quarterly
  • 3SC 13G/A5%+ passive stake · event-driven
  • 2DEF 14AProxy statement · annual (pre-meeting)
  • 2DEFA14ASEC filing
  • 2PRE 14ASEC filing
  • 210-KAnnual report · annual
  • 2424B5Prospectus supplement · event-driven
  • 2SC 13G5%+ passive stake · event-driven
  • 110-K/AAnnual report · annual
  • 110-Q/AQuarterly report · quarterly
  • 18-K/AMaterial event · event-driven

Profile derived from 40 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1404281&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.